Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Oncolytic polio virotherapy of cancer
Michael C. Brown
, Elena Y. Dobrikova
, Mikhail I. Dobrikov
, Ross W. Walton
, Sarah L. Gemberling
, Smita K. Nair
, Annick Desjardins
, John H. Sampson
, Henry S. Friedman
, Allan H. Friedman
, Douglas S. Tyler
, Darell D. Bigner
, Matthias Gromeier
Research output
:
Contribution to journal
›
Review article
›
peer-review
74
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oncolytic polio virotherapy of cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Polio
100%
Virotherapy
100%
Oncolytic
100%
Oncolytic Virus
100%
Viral
66%
Tumor Cytotoxicity
66%
Oncolytic Viral Therapy
66%
Virus
33%
Clinical Trials
33%
Cytotoxicity
33%
Cancer Treatment
33%
Chimera
33%
Adaptive Immune Response
33%
Immunogenic
33%
Clinical Translation
33%
Effector Responses
33%
Innate Antiviral
33%
Replication Strategy
33%
Oncolytic Virotherapy
33%
Tumor Virus Infections
33%
Rhinovirus
33%
Immune Effectors
33%
Targeting Cancer
33%
Antineoplastic
33%
PVSRIPO
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
100%
Virotherapy
100%
Oncolytic Virus
100%
Cytotoxicity
100%
Immunotherapy
66%
Clinical Trial
33%
Infection
33%
Antivirus Agent
33%
Anticarcinogen
33%
Virus
33%
Rhinovirus
33%
Immunology and Microbiology
Virotherapy
100%
Cytotoxicity
100%
Oncolytic Virus
100%
Immunotherapy
66%
Infectious Disease
33%
Rhinovirus
33%
Virus
33%
Infection
33%
Replication
33%
Biochemistry, Genetics and Molecular Biology
Virus
100%
Cytotoxicity
75%
Clinical Trial
25%
Rhinovirus
25%